Nontuberculous mycobacteria in solid organ transplant.

Area of Science:

• Immunology
• Infectious Diseases
• Transplant Medicine

Background:

• Nontuberculous mycobacteria (NTM) are increasingly recognized as significant pathogens, particularly in solid organ transplant (SOT) candidates and recipients.
• The prevalence of NTM infections is geographically variable, with a notable predominance in coastal regions.

Purpose of the Study:

• To review the diagnostic challenges associated with NTM infections in transplant populations.
• To explore emerging treatment options and infection prevention strategies for NTM in immunocompromised individuals.

Main Methods:

• Literature review of current guidelines and recent findings on NTM diagnosis and management.
• Analysis of evolving data on novel therapeutic agents and combination therapies.

Main Results:

• Existing guidelines may not fully address the complexities of NTM management in transplant recipients.
• Combination therapies involving agents like avibactam, tedizolid, clofazimine, bedaquiline, liposomal amikacin, and ciprofloxacin have demonstrated efficacy against common NTM species (e.g., Mycobacterium abscessus, Mycobacterium avium complex).

Conclusions:

• Individualized treatment regimens are crucial for optimizing outcomes and improving patient compliance.
• Further prospective, multicenter studies are necessary to establish the incidence of NTM infection and evaluate the efficacy of synergistic treatment combinations in transplant recipients.